Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Heidelberg Pharma AG
XETRA:HPHA
Heidelberg Pharma AG
XETRA:HPHA
Price:
2.35
EUR
-0.42%
Market Closed
Market Cap:
€109.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Heidelberg Pharma AG
XETRA:HPHA
|
DE |
|
Valartis Group AG
SIX:VLRT
|
CH |
|
S
|
Sun Life Financial Inc
SWB:LIE
|
CA |
|
Pluri Inc
NASDAQ:PLUR
|
IL |
|
C
|
Captor Capital Corp
CNSX:CPTR
|
CA |
|
M
|
MegaStudyEdu Co Ltd
KOSDAQ:215200
|
KR |
|
D
|
Dynex Capital Inc
F:DYT1
|
US |
|
Sartorius Stedim Biotech SA
F:56S1
|
FR |
|
Guotai Junan International Holdings Ltd
F:GUE
|
HK |
|
Laurentian Bank of Canada
TSX:LB
|
CA |
|
Exelon Corp
NASDAQ:EXC
|
US |
|
D
|
Del Monte Corp
F:FDM
|
KY |
Wall St Price Targets
HPHA Price Forecast
Based on 4 analysts
Based on 4 analysts
+139% Upside
from
€2.35
today
Heidelberg Pharma AG (HPHA)’s 12-month stock price forecast through October 2027 has a consensus target of €5.61, implying 139% upside. The forecast is based on price targets from 4 Wall Street analysts.
HPHA Analyst Rating
No ratings yet
No ratings yet
Heidelberg Pharma AG Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPHA's stock price target?
Price Target
5.61
EUR
5.61
EUR
According to Wall Street analysts, the average 1-year price target for HPHA is 5.61 EUR with a low forecast of 5.56 EUR and a high forecast of 5.78 EUR.
What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%
202%
Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.
What is the Gross Profit forecast for Heidelberg Pharma AG?
Projected CAGR
-21%
-21%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next -5 years is -21%.